SEC 13F Intelligence

Crabel Capital Management, LLC / ALXN

Crabel Capital Management, LLC’s Alexion Pharmaceuticals Inc Position

Does Crabel Capital Management, LLC own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 41.8K shares worth $8M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q2 2021
Shares
41.8K
% of Portfolio
+1.58%
Quarters Held
3
position exited

Position History ALXN

Reported value by quarter
Q4 ’20: $520,000Q4 ’20Q1 ’21: $3MQ1 ’21Q2 ’21: $8MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202141.8K$8M+1.58%
Q1 202121.3K$3M+0.85%
Q4 20203.3K$520,000+0.13%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Crabel Capital Management, LLC’s full portfolio or all institutional holders of ALXN.